1
|
Abbate M, Zoja C and Remuzzi G: How does
proteinuria cause progressive renal damage. J Am Soc Nephrol.
17:2974–2984. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Waller JR, Brook NR, Bicknell GR, Murphy
GJ and Nicholson ML: Mycophenolate mofetil inhibits intimal
hyperplasia and attenuates the expression of genes favouring smooth
muscle cell proliferation and migration. Transplant Proc.
37:164–166. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Roos N, Poulalhon N, Farge D, Madelaine I,
Mauviel A and Verrecchia F: In vitro evidence for a direct
antifibrotic role of the immunosuppressive drug mycophenolate
mofetil. J Pharmacol Exp Ther. 321:583–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Petrova DT, Brandhorst G, Brehmer F, Gross
O, Oellerich M and Armstrong VW: Mycophenolic acid displays
IMPDH-dependent and IMPDH-independent effects on renal fibroblast
proliferation and function. Ther Drug Monit. 32:405–412. 2010.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Guo X and Wang XF: Signaling cross-talk
between TGF-beta/BMP and other pathways. Cell Res. 19:71–88. 2009.
View Article : Google Scholar
|
6
|
Assinder SJ, Dong Q, Kovacevic Z and
Richardson DR: The TGF-beta, PI3K/Akt and PTEN pathways:
Established and proposed biochemical integration in prostate
cancer. Biochem J. 417:411–421. 2009. View Article : Google Scholar
|
7
|
Danielpour D: Functions and regulation of
transforming growth factor-beta (TGF-beta) in the prostate. Eur J
Cancer. 41:846–857. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nowak DE, Tian B, Jamaluddin M, Boldogh I,
Vergara LA, Choudhary S and Brasier AR: RelA Ser276 phosphorylation
is required for activation of a subset of NF-kappaB-dependent genes
by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol
Cell Biol. 28:3623–3638. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Dummler B and Hemmings BA: Physiological
roles of PKB/Akt isoforms in development and disease. Biochem Soc
Trans. 35:231–235. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Takase O, Marumo T, Imai N, Hirahashi J,
Takayanagi A, Hishikawa K, Hayashi M, Shimizu N, Fujita T and
Saruta T: NF-kappaB-dependent increase in intrarenal angiotensin II
induced by proteinuria. Kidney Int. 68:464–473. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Burton CJ, Harper SJ, Bailey E, Feehally
J, Harris KP and Walls J: Turnover of human tubular cells exposed
to proteins in vivo and in vitro. Kidney Int. 59:507–514. 2001.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ,
Kalluri R, Müller GA and Neilson EG: Role of basic fibroblast
growth factor-2 in epithelial-mesenchymal transformation. Kidney
Int. 61:1714–1728. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Tareeva IE, Kutyrina IM, Nikolaev Alu,
Lifshits NL and Shvetsov MIu: Ways to inhibit development of
chronic renal failure. Ter Arkh. 72:9–14. 2000.In Russian.
|
14
|
Li MX and Liu BC: Epithelial to
mesenchymal transition in the progression of tubulointerstitial
fibrosis. Chin Med J (Engl). 120:1925–1930. 2007.
|
15
|
Eddy AA: Molecular basis of renal
fibrosis. Pediatr Nephrol. 15:290–301. 2000. View Article : Google Scholar
|
16
|
Klahr S and Morrissey J: Progression of
chronic renal disease. Am J Kidney Dis. 41(3 Suppl 1): S3–S7. 2003.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Owen WF Jr: Patterns of care for patients
with chronic kidney disease in the United States: Dying for
improvement. J Am Soc Nephrol. 14(7 Suppl 2): S76–S80. 2003.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Baer PC, Gauer S, Hauser IA, Scherberich
JE and Geiger H: Effects of mycophenolic acid on human renal
proximal and distal tubular cells in vitro. Nephrol Dial
Transplant. 15:184–190. 2000. View Article : Google Scholar : PubMed/NCBI
|
19
|
Qi W, Chen X, Poronnik P and Pollock CA:
Transforming growth factor-beta/connective tissue growth factor
axis in the kidney. Int J Biochem Cell Biol. 40:9–13. 2008.
View Article : Google Scholar
|
20
|
Isaka Y, Tsujie M, Ando Y, Nakamura H,
Kaneda Y, Imai E and Hori M: Transforming growth factor-beta 1
antisense oligodeoxynucleotides block interstitial fibrosis in
unilateral ureteral obstruction. Kidney Int. 58:1885–1892. 2000.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Samarakoon R, Overstreet JM, Higgins SP
and Higgins PJ: TGF-β1→SMAD/p53/USF2→PAI-1 transcriptional axis in
ureteral obstruction-induced renal fibrosis. Cell Tissue Res.
347:117–128. 2012. View Article : Google Scholar
|
22
|
Ma FY, Tesch GH, Ozols E, Xie M, Schneider
MD and Nikolic-Paterson DJ: TGF-β1-activated kinase-1 regulates
inflammation and fibrosis in the obstructed kidney. Am J Physiol
Renal Physiol. 300:F1410–F1421. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Chen ZJ: Ubiquitin signalling in the
NF-kappaB pathway. Nat Cell Biol. 7:758–765. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hirai K, Hayashi T, Chan PH, Zeng J, Yang
GY, Basus VJ, James TL and Litt L: PI3K inhibition in neonatal rat
brain slices during and after hypoxia reduces phospho-Akt and
increases cytosolic cytochrome c and apoptosis. Brain Res Mol Brain
Res. 124:51–61. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zdychová J and Komers R: Emerging role of
Akt kinase/protein kinase B signaling in pathophysiology of
diabetes and its complications. Physiol Res. 54:1–16.
2005.PubMed/NCBI
|
26
|
Runyan CE, Schnaper HW and Poncelet AC:
The phosphati-dylinositol 3-kinase/Akt pathway enhances
Smad3-stimulated mesangial cell collagen I expression in response
to transforming growth factor-beta1. J Biol Chem. 279:2632–2639.
2004. View Article : Google Scholar
|